ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients. Daoud A, Ali H, Rao V, Rohan V, et al. Ren Fail 2021;43:1463-1464.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Daoud A, Ali H, Rao V, Rohan V, et al. ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients. Ren Fail 2021;43:1463-1464.
PMID: 34704916